You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
American Association for Clinical Chemistry
Improving healthcare through laboratory medicine
Home
|
Customer Service
|
Site Map
|
Cart
|
Login
About AACC
Members
Events
Government & Public Affairs
Resource Centers
Professional Development
Publications
AACC Store
>
Members
>
NACB - The AACC Academy
>
NACB Blog
Recent Posts
Newborn Screening for Severe Combined Immunodeficiency (SCID): Should it be performed?
Are reference change values more useful than population-based reference intervals?
Autoimmune diabetes and related conditions
Where Is the Hemoglobin S?
Categories
Cancer and Tumor Markers
Case Study
Clinical Translational Science/Proteomics
CVD/Markers/Risk Factors
Diabetes/Endocrinology
Government Affairs/Patient Safety
Immunology/Infectious Disease
Instrumentation/Technology
Management/Medical Informatics
Molecular Pathology and Genetics
New/Other Disease Markers
Nutrition
POC Testing
Renal/GI/Hepatic
Special Populations
TDM/Toxicology
Archives
Year
: 2013
May 2013
April 2013
March 2013
February 2013
January 2013
Year
: 2012
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
Year
: 2011
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
RSS Feed
NACB Blog
Do We Need Proficiency Testing for Institutional, Grant, and Editorial Review Boards?
7/18/2012 5:35 PM |
Comments (0)
Recommend (466)
By
Doug Dix, PhD, DABCC, FACB
No professionals care more about quality than clinical chemists. We monitor the precision of every assay, the relevance of every test, and the accuracy of every laboratory. But we let institutional, grant, and editorial review boards operate behind the scenes and without oversight (1). No one has e...(
Read More
)
Posted at 7/18/2012 5:35 PM | Tags:
Government Affairs/Patient Safety
Critical Results: Is Your Lab’s Definition Crisp or Muddled?
2/7/2012 8:51 AM |
Comments (1)
Recommend (902)
By
Gregory J. Buffone, PhD
Since the introduction of critical results reporting by Lundberg over 30 years ago certain issues have remained controversial to this day, at least at our institution, e.g., is it critical or is it simply medically important information? And, if it’s medically important is the laboratory obligate...(
Read More
)
Posted at 2/7/2012 8:51 AM | Tags:
Management/Medical Informatics
|
Government Affairs/Patient Safety
Occupy the Laboratory?
11/29/2011 8:42 AM |
Comments (0)
Recommend (695)
By
James Faix, MD
There have been many salutes to Rich Flaherty this year, marking his retirement after serving as AACC’s Executive Vice President for two decades. But it is unlikely that any will match the warm remembrance he himself offered at the recent fall meeting of the Southeast Local Section. On a particular...(
Read More
)
Posted at 11/29/2011 8:42 AM | Tags:
Government Affairs/Patient Safety
Laboratory Developed Tests: How Will FDA Regulation Affect Us?
10/25/2011 8:15 AM |
Comments (1)
Recommend (787)
By
Patricia M. Jones, PhD, DABCC, FACB
Laboratory developed tests (LDTs) used to be referred to as home-brew tests or in-house tests. These are assays that are developed in one’s own laboratory, and they include a wide range of tests. LDTs can be as simple as colorimetric tests like the old Apt-Downey test for fetal hemoglobin, all the ...(
Read More
)
Posted at 10/25/2011 8:15 AM | Tags:
Government Affairs/Patient Safety
1 - 4
About AACC
|
Members
|
Government & Public Affairs
|
Resource Centers
|
Professional Development
|
Publications
Home
|
Customer Service
|
Site Map
|
AACC Store
|
Login
Contact Us
|
Privacy Policy and Legal Disclaimer
|
Join AACC
©2013 American Association for Clinical Chemistry
1850 K Street, NW Suite 625
Washington, DC 20006
Phone: (800) 892-1400 | Fax: (202) 887-5093